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1046Objective: Congenital heart surgery outcomes analysis requires reliable methods of estimating the risk of
adverse outcomes. Contemporary methods focus primarily on mortality or rely on expert opinion to estimate
morbidity associated with different procedures. We created an objective, empirically based index that reflects
statistically estimated risk of morbidity by procedure.
Methods:Morbidity risk was estimated using data from 62,851 operations in the Society of Thoracic Surgeons
Congenital Heart Surgery Database (2002-2008). Model-based estimates with 95% Bayesian credible intervals
were calculated for each procedure’s average risk of major complications and average postoperative length of
stay. These 2 measures were combined into a composite morbidity score. A total of 140 procedures were as-
signed scores ranging from 0.1 to 5.0 and sorted into 5 relatively homogeneous categories.
Results: Model-estimated risk of major complications ranged from 1.0% for simple procedures to 38.2% for
truncus arteriosus with interrupted aortic arch repair. Procedure-specific estimates of average postoperative
length of stay ranged from 2.9 days for simple procedures to 42.6 days for a combined atrial switch and Rastelli
operation. Spearman rank correlation between raw rates of major complication and average postoperative length
of stay was 0.82 in procedures with n greater than 200. Rate of major complications ranged from 3.2% in
category 1 to 30.0% in category 5. Aggregate average postoperative length of stay ranged from 6.3 days in cat-
egory 1 to 34.0 days in category 5.
Conclusions: Complication rates and postoperative length of stay provide related but not redundant information
about morbidity. The Morbidity Scores and Categories provide an objective assessment of risk associated with
operations for congenital heart disease, which should facilitate comparison of outcomes across cohorts with dif-
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Contemporary efforts to describe and compare congenital
heart surgery outcomes across institutions have evolved to
include (1) use of clinical registry data, rather than admin-
istrative data from the hospital bill to evaluate outcomes; (2)
use of empiric rather than opinion-based models to adjust
for differences in case complexity across institutions; and
(3) recognition that focusing solely on in-hospital mortality
overlooks 96% of patients who survive to hospital dis-
charge and the important morbidities that they may
experience.1
In 2009, an empirically based tool for analyzing mortality
associated with congenital heart surgery was introduced.
The Society of Thoracic Surgeons-European Association
for Cardiothoracic Surgery (STS-EACTS) Congenital
Heart Surgery Mortality Score and Categories are based
on analysis of 148 different types of operations performed
in 77,294 patients.2 Procedures are assigned to 1 of 5 cate-
gories on the basis of a similar risk of in-hospital death.gery c April 2013
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CrI ¼ credible interval
ICU ¼ intensive care unit
PLOS ¼ postoperative length of stay
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Congenital Heart Surgery Database
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¼ Society of Thoracic Surgeons-
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the highest risk of death. In addition, each procedure re-
ceives a numeric score ranging from 0.1 to 5.0 that ex-
presses mortality risk on a more continuous scale. The
STS-EACTS Mortality Categories are intended to facilitate
analysis of outcomes by grouping procedures with similar
risk of in-hospital mortality.
Although congenital heart surgery outcomes analyses
have traditionally focused on mortality, comprehensive as-
sessment requires attention to other end points. Nonfatal
events, such as stroke and renal failure, are major determi-
nants of hospital cost and patients’ health status after sur-
gery. In addition, postprocedure length of hospital stay
provides useful direct information about resource use and
indirect proxy information about a patient’s condition.3,4
Although such measures are captured in clinical registries,
tools for analyzing these end points are lacking.
The goal of the present study was to develop a new sys-
tem for classifying congenital heart surgery procedures on
the basis of their potential for morbidity using empirical
data from the STS Congenital Heart Surgery Database
(STSCHSD). There were 4 specific objectives:
 to develop a morbidity metric based on both the occur-
rence of complications that have a significant and durable
impact on patient health and utilization of health care
resources;
 to estimate the average amount of patient morbidity by
procedure type;
 to convert these procedure-specific morbidity estimates
into a scale ranging from 0.1 to 5.0 (range was chosen for
consistency with the STS-EACTS Mortality Score2); and
 to group procedures with similar estimated morbidity risk
into 5 relatively homogeneous categories that were de-
signed to minimize within-category variation and to serve
as a stratificationvariable that can be used to adjust for case
mix when analyzing outcomes and comparing institutions.
TheMorbiditymetricwas developed primarily for the pur-
pose of grouping types of procedures to better describe case
mix, as was the STS-EACTS Mortality metric. The intent
was not to assess or predict outcomes for an individual patient
or surgeon, for which other types of analyses may be used.The Journal of Thoracic and CarMATERIALS AND METHODS
Study Population
TheSTSCHSDhas been described.5 TheDukeClinicalResearch Institute
serves as the data analysis center for STS databases and has an agreement and
institutional review board approval to analyze the aggregate deidentified data
for research purposes. For this study, operations were included if they took
place between January 1, 2002, and December 31, 2008, and were 1 of the
148 types of cardiovascular procedures for which the STS-EACTSMortality
Score is defined.2 Operations performed at centers with no more than 10%
missing data for complications, mortality, or postoperative length of stay
(PLOS) were eligible for inclusion in the analysis. From eligible centers, in-
dividual operations with missing data for complications, mortality, or PLOS
were excluded. Of 63,297 potentially eligible operations, 446 individual op-
erations were excluded on the basis of missing data regarding complications
(n¼ 273), PLOS (n¼ 151), or mortality (n¼ 22).
Additional inclusion and exclusion criteria were identical to those used
for developing the STS-EACTS Mortality Score.2 Only the first operation
of each hospital admission was analyzed. The final study population con-
sisted of 62,851 operations classified into 148 procedure types at 68 cen-
ters. Results are presented for the subset of 140 procedure types having
at least 10 eligible cases (62,819 total operations; 99.9%).
Classification of Multiple-Procedure Operations
Several operations in the analysis represent combinations of 2 or more
procedures. These are analyzed as combined procedures because the com-
plexity of the combination is regarded as being different from the complex-
ity of the component procedures when performed in isolation. For each of
these combined procedures, unique procedure codes were subsequently as-
signed in STSCHSD version 3.0. Because all data in this analysis predate
version 3.0, classification of multiple-procedure operations in this study
follows guidelines set forth previously in development of the STS-
EACTS Mortality Score and Categories.2
End Points
Morbidity was quantified for each procedure on the basis of the propor-
tion of patients experiencingmajor complications and by the average PLOS
(Table 1). Major complication was defined as the occurrence of any 1 or
more of the 6 complications listed in Table 2. These complications repre-
sent definitive outcomes that can be ascertained reliably and that are likely
to have significant and durable impact on patient health. The unadjusted
rate of major complications is defined as the percent of operations that
were associated with the occurrence of 1 or more of the major complica-
tions listed in Table 2. PLOS was defined as the number of days from
the date of operation to the date of discharge and was determined for all
patients, including those who died in-hospital.
Analysis
Statistics calculated for each procedure type included the number of el-
igible operations, the percent of patients experiencing major complica-
tions, the 95% binomial confidence interval for the probability of major
complications, and the average and interquartile range (25th and 75th per-
centiles) of PLOS.Model-based estimates of each procedure’s average risk
of major complications and average PLOS were calculated by hierarchical
modeling and presented alongwith 95%Bayesian credible intervals (CrIs).
Details of these calculations are provided in Appendix 1.
Creation of Morbidity Scores
To facilitate ranking and grouping of procedures, average risk of major
complications and average PLOS were combined into a single composite
morbidity measure. To account for different measurement scales, the 2 in-
dividual measures were rescaled to have the same standard deviation
(Appendix 3). They were then summed together. The resulting composite
morbidity measure was the basis of the proposed Morbidity Scores anddiovascular Surgery c Volume 145, Number 4 1047
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to 5.0 (STS Congenital Heart Surgery Morbidity Score). The range was
chosen to be the same as the existing STS-EACTS Mortality Score. Scores
were assigned by shifting and rescaling the procedure-specific composite
morbidity estimates to lie in the interval from 0.1 to 5.0 and then rounding
to 1 decimal place.
Creation of Morbidity Categories
Procedures were sorted by increasing estimated morbidity and parti-
tioned into 5 relatively homogeneous categories (STS Congenital Heart
Surgery Morbidity Categories). This number of categories was chosen to
match the number of STS-EACTS Mortality Categories.2 A computer pro-
gram was used to search for category cutpoints that were optimal for min-
imizing within-category variance and maximizing between-category
variance of the composite morbidity measure. The relationship between
the number of categories and the degree of within-category homogeneity
was assessed (Figure E1).
Sensitivity Analyses
Sensitivity analyses were performed to assess whether the ranking of pro-
cedures depended heavily on the choice of statistical methodology. The
Spearman rank correlation coefficientwasused toquantify the extent towhich
rankings differed. Differences were also assessed graphically by plotting
estimates of the same quantity calculated by 2 different statistical methods.
Assessment of Statistical Reliability
Finally, we estimated the statistical precision (reliability) of the esti-
mated rates of major complication, average PLOS, and composite morbid-
ity. Reliability of a set of estimates is conventionally defined as the
proportion of between-unit variation that is explained by true between-
unit differences (ie, signal) as opposed to random statistical fluctuations
(ie, noise). A mathematically equivalent definition is the squared correla-
tion between a measurement and the true value. In our case, reliability
was defined as the squared Pearson correlation between each procedure’s
estimated and true amount of morbidity. Reliability could not be calculated
directly (because the ‘‘true’’ morbidity values are unknown) but was esti-
mated by hierarchical modeling, as described in Appendix 1.
RESULTS
Sample sizes per procedure ranged from 1 to 4868. The
140 procedures with at least 10 cases are listed in Table 1
along with their sample sizes, raw andmodel-based morbid-
ity estimates, and Morbidity Scores and Categories.
Model-estimated risk of major complications ranged from
1.0% for atrial septal defect repair to 38.2% for truncus arte-
riosus with interrupted aortic arch repair. Procedure-specific
estimates of average PLOS ranged from 2.9 days for implant-
able cardioverter defibrillator procedure to 34.6 days for
a stage 1 Norwood procedure and 42.6 days for a combined
atrial switch andRastelli procedure for congenitally corrected
transposition. The Spearman rank correlation between raw
rates of major complication and average PLOS was 0.63
(Figure 1) in procedures with at least 10 cases and 0.82 in
procedures with at least 200 cases. This degree of correlation
suggests that complication rates and PLOS provide related,
but not redundant, information about morbidity.
Procedure-specific overall morbidity was defined as
0.141 3 percentage rate of major complications þ
0.162 3 average PLOS in days. The numbers 0.141 and1048 The Journal of Thoracic and Cardiovascular Sur0.162 were calculated as the reciprocals of the standard de-
viations of the percentage rate of major complications and
average PLOS, respectively. The STS Morbidity Score
was obtained by rescaling this overall morbidity measure
to lie in the interval 0.1 to 5.0. Thus, by design it ranged
from 0.1 to 5.0. Procedures with the least morbidity (STS
Morbidity Score ¼ 0.1) include atrial septal defect repair
and implantable cardioverter defibrillator procedures. The
procedure with the greatest morbidity (STS Morbidity
Score ¼ 5.0) was repair of truncus arteriosus with interrup-
ted aortic arch.
STS Morbidity Categories were obtained by grouping
procedures into 5 unequally sized categories (1¼ least mor-
bidity, 5 ¼ most morbidity) chosen to be maximally homo-
geneous with respect to overall morbidity. The number of
procedures assigned to categories 1, 2, 3, 4, and 5 were 36,
43, 36, 21, and 4, respectively. The rate of major complica-
tion ranged from 3.2% in category 1 to 30.0% in category 5.
The aggregate average PLOS ranged across categories from
6.3 days in category 1 to 34.0 days in category 5.
Several analyses were performed to address potential
methodological concerns with the composite measures
used in this analysis. First, we addressed potential issues re-
lated to ‘‘Major Complication,’’ which is a composite des-
ignating the occurrence of any 1 or more of 6 individual
complications. The observed rate of discharge mortality
for patients who experienced at least 1 major complication
was 23.5% (Table 2) in comparison with 2.0% among pa-
tients who experienced none of the major complications.
When end points in a composite occur with differing fre-
quencies, the more frequent end points may sometimes
dominate.6 As shown in Table 2, the aggregate rate of major
complications ranged from 0.8% for ‘‘postoperative neuro-
logic deficit persisting at discharge’’ to 4.7% for ‘‘un-
planned reoperation.’’ To verify that each individual
complication contributed statistical information but did
not dominate the composite, we calculated the Spearman
rank correlation coefficient between procedure-specific
rates of each individual complication and rates of any major
complication. These correlations ranged from 0.37 for heart
block to 0.79 for unplanned reoperation. Thus, although un-
planned reoperation explained much of the variation in the
major complication end point, no single item dominated.
All 6 complications contributed statistical information.
Second, we assessed the impact of modifying the list of
major complications to include mortality. Although mortal-
ity was ultimately excluded, we thought it was important to
knowwhether results would be similar or different had mor-
tality been included. To address this, we calculated 2 ver-
sions of the major complication end point (1 including
and 1 excluding mortality) and compared them. As shown
in Figure 2, the 2 major complication end points were
highly correlated but not perfectly related. The rank
correlation coefficient between them was 0.97.gery c April 2013
TABLE 1. Procedure names, morbidity categories and scores, and data for model development
Procedure name (STS code) No.
Morbidity PLOS (d) Any major complications
Category Score Average (IQR)
Model-based
estimate
(95% CrI) Raw (95% CI)
Model
(95% CrI)
ASD repair, patch (30) 2469 1 0.1 4.1 (3.0-4.0) 4.1 (3.8-4.4) 0.8% (0.5-1.2) 1.0% (0.7-1.4)
ICD (AICD) implantation (1470) 358 1 0.1 3.2 (1.0-3.0) 3.2 (2.6-3.9) 1.7% (0.8-3.6) 2.1% (1.1-3.5)
ICD (AICD) procedure (1480) 156 1 0.1 2.8 (1.0-3.0) 2.9 (2.1-3.7) 2.6% (1.0-6.4) 2.9% (1.3-5.1)
ASD repair, patchþPAPVC repair (3100) 319 1 0.1 3.7 (3.0-4.0) 3.7 (3.4-3.9) 1.6% (0.7-3.6) 2.1% (1.1-3.7)
Pacemaker procedure (1460) 1413 1 0.2 3.9 (0.0-3.0) 3.9 (3.1-4.7) 2.0% (1.4-2.8) 2.1% (1.5-2.9)
ASD repair, primary closure (20) 947 1 0.2 5.0 (3.0-4.0) 5.0 (4.4-5.6) 1.3% (0.7-2.2) 1.6% (1.0-2.4)
AVC (AVSD) repair, partial (incomplete)
(PAVSD) (190)
772 1 0.3 5.1 (3.0-5.0) 5.1 (4.6-5.7) 2.1% (1.3-3.3) 2.3% (1.5-3.3)
DCRV repair (570) 352 1 0.3 5.1 (3.0-5.0) 5.1 (4.6-5.6) 2.8% (1.6-5.1) 3.1% (1.7-4.9)
PAPVC repair (260) 370 1 0.4 5.4 (3.0-5.0) 5.4 (4.2-6.7) 2.4% (1.3-4.6) 2.8% (1.6-4.5)
Vascular ring repair (1360) 1006 1 0.4 6.3 (2.0-4.0) 6.3 (5.4-7.2) 1.5% (0.9-2.4) 1.8% (1.2-2.6)
Pacemaker implantation, permanent (1450) 1147 1 0.4 5.7 (1.0-4.0) 5.7 (4.8-6.6) 2.4% (1.7-3.5) 2.6% (1.8-3.6)
Aneurysm, pulmonary artery, repair (1740) 16 1 0.4 4.7 (3.0-5.0) 4.9 (2.6-7.3) 0.0% (0.0-19.4) 3.6% (1.2-7.9)
Coronary artery fistula ligation (1290) 29 1 0.4 4.9 (3.0-6.0) 5.0 (3.6-6.3) 3.4% (0.2-17.2) 3.9% (1.6-8.3)
Aortic stenosis, subvalvar, repair (780) 1573 1 0.4 4.7 (3.0-5.0) 4.7 (4.5-5.0) 4.3% (3.4-5.4) 4.2% (3.3-5.2)
Valve replacement, pulmonic (600) 1097 1 0.4 5.3 (3.0-6.0) 5.3 (5.0-5.6) 3.6% (2.7-4.9) 3.6% (2.7-4.8)
Coarctation repair, interposition graft (1250) 102 1 0.4 6.1 (4.0-6.8) 6.1 (5.0-7.3) 2.0% (0.5-6.9) 3.2% (1.4-5.9)
Valvuloplasty, pulmonic (590) 230 1 0.5 6.9 (3.0-5.8) 6.9 (5.2-8.5) 1.7% (0.7-4.4) 2.7% (1.3-4.6)
Atrial baffle procedure (non-Mustard,
non-Senning) (310)
23 1 0.5 6.3 (3.0-7.5) 6.4 (4.8-8.0) 0.0% (0.0-14.3) 3.8% (1.3-8.1)
VSD repair, primary closure (100) 448 1 0.5 6.0 (3.0-5.0) 6.0 (5.2-6.8) 4.7% (3.1-7.1) 4.6% (3.0-6.6)
Valvuloplasty, aortic (660) 667 1 0.6 6.4 (3.0-6.0) 6.4 (5.6-7.2) 4.2% (2.9-6.0) 4.2% (2.9-5.8)
Conduit placement, LV to PA (620) 19 1 0.6 6.8 (4.0-9.0) 6.8 (5.0-8.7) 0.0% (0.0-16.8) 4.0% (1.4-8.8)
Aortic root replacement, valve sparing (735) 102 1 0.6 6.0 (4.0-7.0) 6.0 (5.4-6.6) 5.9% (2.7-12.2) 5.1% (2.6-8.9)
VSD repair, patch (110) 4868 1 0.6 7.7 (3.0-7.0) 7.7 (7.3-8.0) 3.3% (2.9-3.9) 3.4% (2.9-3.9)
AVC (AVSD) repair, intermediate
(transitional) (180)
344 1 0.6 6.9 (3.0-6.0) 7.0 (5.8-8.1) 4.7% (2.9-7.4) 4.7% (2.9-6.9)
Coarctation repair, end to end (1210) 1214 1 0.6 9.0 (3.0-7.0) 8.9 (7.9-9.9) 2.2% (1.5-3.2) 2.5% (1.7-3.4)
TOF repair, ventriculotomy, nontransannular
patch (360)
693 1 0.7 7.3 (4.0-7.0) 7.3 (6.7-7.8) 4.8% (3.4-6.6) 4.8% (3.3-6.4)
Conduit reoperation (580) 1244 1 0.7 7.2 (4.0-6.0) 7.2 (6.6-7.9) 5.4% (4.3-6.8) 5.3% (4.2-6.6)
PFO, primary closure (10) 129 1 0.7 7.4 (4.0-7.0) 7.5 (5.9-9.1) 5.4% (2.7-10.8) 5.2% (2.7-8.7)
TOF repair, no ventriculotomy (350) 768 1 0.7 8.3 (5.0-8.0) 8.3 (7.7-9.0) 4.2% (3.0-5.8) 4.3% (3.0-5.7)
Ross procedure (740) 480 1 0.7 5.9 (4.0-6.0) 5.9 (5.5-6.3) 7.9% (5.8-10.7) 7.4% (5.4-9.8)
PA, reconstruction (plasty), main (trunk)
(530)
175 1 0.8 7.1 (3.0-6.0) 7.3 (5.7-8.9) 6.3% (3.5-10.9) 5.8% (3.3-9.2)
Atrial fenestration closure (85) 19 1 0.8 7.6 (4.0-10.0) 7.8 (5.2-10.5) 5.3% (0.3-24.6) 5.3% (2.0-11.2)
ASD, common atrium (single atrium),
septation (50)
41 1 0.8 8.5 (3.0-5.0) 8.7 (4.0-13.5) 2.4% (0.1-12.6) 4.6% (1.7-9.5)
Valvuloplasty, mitral (830) 1365 1 0.8 8.7 (4.0-7.0) 8.7 (8.0-9.4) 5.0% (3.9-6.3) 5.0% (4.0-6.2)
Cor triatriatum repair (290) 127 1 0.8 9.6 (4.0-7.0) 9.5 (6.9-12.2) 3.1% (1.2-7.8) 4.3% (2.1-7.4)
PA debanding (1650) 75 1 0.8 8.5 (4.0-9.5) 8.5 (6.6-10.4) 5.3% (2.1-12.9) 5.4% (2.5-9.6)
AVR, bioprosthetic (690) 90 2 0.9 6.6 (3.2-6.0) 6.8 (5.4-8.3) 11.1% (6.1-19.3) 8.3% (4.4-13.8)
Aortic stenosis, supravalvar, repair (790) 268 2 0.9 7.7 (4.0-7.0) 7.8 (6.5-9.1) 7.8% (5.2-11.7) 7.3% (4.7-10.4)
Coarctation repair, end to end, extended
(1220)
1773 2 0.9 11.6 (4.0-10.0) 11.5 (10.6-12.5) 2.9% (2.2-3.8) 3.1% (2.3-3.9)
Sinus of Valsalva, aneurysm repair (810) 33 2 0.9 7.0 (4.0-9.0) 7.3 (5.5-9.2) 15.2% (6.7-30.9) 8.4% (3.6-15.7)
Aortopexy (1365) 50 2 1 20.7 (2.0-8.5) 11.1 (2.6-19.3) 0.0% (0.0-7.1) 4.4% (1.4-9.3)
Valvuloplasty, tricuspid (460) 927 2 1 9.4 (4.0-8.0) 9.4 (8.2-10.7) 6.4% (5.0-8.1) 6.3% (4.9-7.9)
Aortic root replacement, bioprosthetic (715) 47 2 1 6.8 (4.0-7.0) 7.1 (5.6-8.6) 14.9% (7.4-27.7) 9.1% (4.2-16.0)
Conduit placement, other (1772) 38 2 1 9.5 (4.0-7.0) 9.9 (5.3-14.4) 5.3% (1.5-17.3) 6.0% (2.4-11.8)
Pericardiectomy (930) 63 2 1 11.8 (4.0-10.5) 11.1 (7.6-14.8) 1.6% (0.1-8.5) 4.6% (1.9-8.8)
(Continued)
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TABLE 1. Continued
Procedure name (STS code) No.
Morbidity PLOS (d) Any major complications
Category Score Average (IQR)
Model-based
estimate
(95% CrI) Raw (95% CI)
Model
(95% CrI)
Bidirectional cavopulmonary anastomosis
(bidirectional Glenn) (1670)
2042 2 1 9.7 (4.0-9.0) 9.7 (9.1-10.3) 6.5% (5.5-7.6) 6.4% (5.4-7.6)
RVOT procedure (510) 1426 2 1 9.8 (4.0-8.0) 9.8 (8.8-10.9) 6.6% (5.4-8.0) 6.5% (5.4-7.8)
Fontan, TCPC, lateral tunnel, nonfenestrated
(980)
140 2 1 10.0 (4.8-12.0) 10.1 (8.6-11.4) 6.4% (3.4-11.8) 6.4% (3.5-10.1)
1 1/2 ventricular repair (520) 20 2 1 8.7 (4.0-7.0) 9.5 (5.2-14.0) 10.0% (2.8-30.1) 7.1% (2.6-15.1)
Anomalous systemic venous connection
repair (330)
200 2 1.1 10.1 (4.0-10.0) 10.2 (8.2-12.2) 6.5% (3.8-10.8) 6.5% (3.8-9.8)
Mitral stenosis, supravalvar mitral ring repair
(840)
76 2 1.1 10.0 (4.0-8.0) 10.4 (5.8-14.7) 6.6% (2.8-14.5) 6.6% (3.0-11.6)
PDA closure, surgical (1330) 1507 2 1.1 14.1 (2.0-9.0) 13.8 (12.3-15.3) 2.6% (1.9-3.5) 2.9% (2.2-3.8)
Hemi-Fontan (1700) 245 2 1.1 11.2 (6.0-12.0) 11.2 (9.7-12.8) 5.7% (3.4-9.4) 6.0% (3.7-8.8)
Aortic aneurysm repair (1380) 264 2 1.1 9.3 (4.0-8.0) 9.6 (7.7-11.5) 8.7% (5.9-12.7) 8.2% (5.4-11.5)
PAPVC, scimitar, repair (270) 64 2 1.2 10.2 (4.0-8.0) 10.6 (6.9-14.3) 7.8% (3.4-17.0) 7.3% (3.5-12.9)
Bilateral bidirectional cavopulmonary
anastomosis (bilateral bidirectional Glenn)
(1690)
360 2 1.2 10.9 (5.0-10.0) 11.0 (9.6-12.5) 7.2% (5.0-10.4) 7.2% (4.9-9.9)
Systemic venous stenosis repair (340) 39 2 1.2 13.7 (4.5-10.0) 12.2 (6.1-18.1) 2.6% (0.1-13.2) 5.9% (2.2-11.9)
Fontan, TCPC, lateral tunnel, fenestrated
(970)
822 2 1.2 11.4 (7.0-12.0) 11.4 (10.7-12.1) 7.1% (5.5-9.0) 7.1% (5.5-8.8)
AVR, homograft (700) 18 2 1.2 7.8 (4.0-6.0) 9.0 (5.5-12.8) 22.2% (9.0-45.2) 9.9% (4.0-19.4)
Aortopulmonary window repair (210) 80 2 1.2 12.5 (5.0-14.0) 12.3 (9.5-15.1) 5.0% (2.0-12.2) 6.2% (3.0-10.7)
TOF repair, ventriculotomy, transannular
patch (370)
1721 2 1.2 11.1 (5.0-11.0) 11.1 (10.3-11.9) 7.7% (6.6-9.1) 7.7% (6.6-8.9)
AVR, mechanical (680) 214 2 1.2 9.2 (5.0-8.0) 9.4 (7.9-10.8) 10.7% (7.3-15.6) 9.7% (6.4-13.9)
Glenn (unidirectional cavopulmonary
anastomosis) (unidirectional Glenn)
(1680)
23 2 1.2 12.3 (5.0-8.0) 12.0 (6.4-17.3) 4.3% (0.2-21.0) 6.9% (2.4-14.2)
ASD partial closure (70) 14 2 1.3 22.2 (6.2-20.0) 12.6 (2.7-22.1) 0.0% (0.0-21.5) 6.9% (1.8-17.3)
PA, reconstruction (plasty), branch,
peripheral (at or beyond the hilar
bifurcation) (550)
163 2 1.3 11.0 (4.0-11.5) 11.2 (8.8-13.6) 9.2% (5.7-14.6) 8.6% (5.2-12.6)
PA, reconstruction (plasty), branch, central
(within the hilar bifurcation) (540)
694 2 1.3 11.7 (4.0-11.0) 11.7 (10.5-13.1) 8.4% (6.5-10.7) 8.3% (6.3-10.4)
Conduit placement, RV to PA (610) 703 2 1.3 11.9 (4.0-10.0) 11.9 (10.4-13.5) 8.1% (6.3-10.4) 8.1% (6.3-10.1)
AVC (AVSD) repair, complete AVSD (170) 2332 2 1.3 12.8 (5.0-13.0) 12.8 (12.1-13.6) 7.0% (6.1-8.1) 7.1% (6.1-8.1)
Partial left ventriculectomy (LV volume
reduction surgery) (Batista) (910)
33 2 1.3 15.7 (6.0-21.0) 14.0 (8.9-18.7) 0.0% (0.0-10.4) 5.9% (2.2-12.1)
LV to aorta tunnel repair (820) 17 2 1.3 12.5 (6.0-20.0) 12.5 (8.4-16.8) 5.9% (0.3-27.0) 7.7% (2.8-15.8)
Coarctation repair, subclavian flap (1230) 179 2 1.4 13.7 (5.0-12.0) 13.5 (11.1-15.9) 6.1% (3.5-10.7) 6.7% (4.0-10.1)
Ventricular septal fenestration (150) 24 2 1.4 17.8 (4.8-9.2) 13.2 (4.5-21.5) 4.2% (0.2-20.2) 7.4% (2.4-15.8)
GlennþPA reconstruction (3300) 458 2 1.4 11.6 (5.0-11.0) 11.7 (10.1-13.2) 9.8% (7.4-12.9) 9.6% (7.2-12.3)
VSD, multiple, repair (130) 142 2 1.5 12.5 (5.0-11.0) 12.7 (9.2-16.0) 9.2% (5.4-15.0) 8.8% (5.2-13.4)
Shunt, ligation, and takedown (1630) 58 2 1.5 11.6 (4.0-11.8) 12.0 (8.9-15.2) 12.1% (6.0-22.9) 10.0% (5.1-16.9)
Aortic root replacement, mechanical (720) 84 2 1.5 9.8 (6.0-11.0) 10.2 (8.3-12.1) 15.5% (9.3-24.7) 12.1% (7.0-18.7)
Cardiac tumor resection (1760) 226 2 1.5 15.4 (4.0-15.8) 14.9 (12.2-17.8) 6.6% (4.1-10.7) 7.2% (4.6-10.4)
Coronary artery bypass (1300) 78 2 1.5 10.5 (4.0-8.0) 11.8 (7.6-16.0) 12.8% (7.1-22.0) 10.7% (5.7-17.1)
Aneurysm, ventricular, right, repair (1720) 80 2 1.5 12.9 (4.0-10.0) 13.1 (9.4-16.8) 10.0% (5.2-18.5) 9.4% (5.0-15.3)
Coarctation repair, patch aortoplasty (1240) 172 3 1.6 14.7 (4.0-14.0) 14.4 (11.0-17.7) 8.1% (4.9-13.2) 8.3% (5.2-12.2)
Pericardial drainage procedure (920) 245 3 1.6 20.0 (4.0-18.0) 17.4 (13.3-21.4) 3.7% (1.9-6.8) 5.2% (3.0-7.9)
(Continued)
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TABLE 1. Continued
Procedure name (STS code) No.
Morbidity PLOS (d) Any major complications
Category Score Average (IQR)
Model-based
estimate
(95% CrI) Raw (95% CI)
Model
(95% CrI)
Arrhythmia surgery ventricular, surgical
ablation (1500)
40 3 1.6 13.6 (4.0-7.0) 13.7 (6.2-21.4) 10.0% (4.0-23.1) 9.6% (3.8-17.8)
Anomalous origin of coronary artery repair
(1291)
287 3 1.6 13.5 (5.0-16.0) 13.5 (11.5-15.6) 10.1% (7.1-14.1) 9.9% (6.8-13.5)
Konno procedure (750) 134 3 1.6 11.5 (5.0-11.0) 12.0 (9.2-14.7) 13.4% (8.7-20.2) 11.8% (7.4-17.0)
Arrhythmia surgery atrial, surgical ablation
(1490)
259 3 1.6 10.4 (5.0-11.0) 10.6 (9.2-12.0) 14.7% (10.9-19.5) 13.4% (9.6-17.7)
Fontan, TCPC, external conduit,
nonfenestrated (1010)
883 3 1.6 13.5 (7.0-14.0) 13.5 (12.6-14.5) 10.4% (8.6-12.6) 10.3% (8.4-12.4)
Aortic root replacement, homograft (730) 99 3 1.7 14.3 (4.5-10.5) 14.2 (9.2-19.1) 10.1% (5.6-17.6) 9.8% (5.3-15.4)
Atrial septal fenestration (80) 18 3 1.7 12.3 (4.0-20.2) 13.3 (8.1-18.7) 16.7% (5.8-39.2) 11.2% (4.3-22.0)
Aneurysm, ventricular, left, repair (1730) 28 3 1.7 12.3 (5.8-16.0) 12.7 (9.7-15.8) 17.9% (7.9-35.6) 12.1% (5.5-22.1)
Arterial switch operation (1110) 1400 3 1.7 14.0 (8.0-15.0) 14.0 (13.2-14.7) 10.8% (9.3-12.5) 10.7% (9.2-12.4)
TOF repair, RV-PA conduit (380) 336 3 1.7 15.8 (6.0-15.0) 15.7 (13.3-18.0) 8.9% (6.3-12.5) 9.1% (6.4-12.2)
Pulmonary artery origin from ascending aorta
(hemitruncus) repair (220)
45 3 1.7 15.6 (8.0-21.0) 15.2 (11.8-18.7) 8.9% (3.5-20.7) 9.6% (4.5-17.1)
Occlusion MAPCA(s) (450) 26 3 1.7 24.8 (6.0-21.8) 15.3 (6.8-24.0) 7.7% (2.1-24.1) 9.6% (3.5-19.4)
Congenitally corrected TGA repair, atrial
switch and Rastelli (1060)
11 3 1.7 42.7 (10.5-23.0) 14.7 (4.4-25.1) 9.1% (0.5-37.7) 10.3% (2.7-24.3)
Fontan, atriopulmonary connection (950) 37 3 1.8 15.2 (7.0-14.0) 14.9 (10.0-19.8) 10.8% (4.3-24.7) 10.4% (4.6-18.8)
REV (1160) 10 3 1.8 21.5 (6.2-11.8) 14.8 (4.7-24.8) 10.0% (0.5-40.4) 10.6% (2.9-24.8)
Pulmonary embolectomy, acute pulmonary
embolus (1802)
10 3 1.8 24.9 (3.0-30.0) 15.0 (5.1-24.9) 10.0% (0.5-40.4) 10.7% (2.8-24.9)
Ligation, pulmonary artery (1790) 12 3 1.8 13.7 (5.5-11.2) 14.4 (7.0-22.1) 16.7% (4.7-44.8) 11.6% (3.6-24.5)
Ebstein’s repair (465) 117 3 1.9 13.8 (4.0-15.0) 14.1 (11.2-16.9) 13.7% (8.6-21.1) 12.5% (7.8-18.5)
Fontan, TCPC, external conduit, fenestrated
(1000)
902 3 1.9 14.9 (7.0-16.0) 14.9 (14.0-15.9) 12.1% (10.1-14.4) 12.0% (10.0-14.1)
Senning (1130) 10 3 1.9 17.9 (8.2-24.8) 15.8 (8.6-22.7) 10.0% (0.5-40.4) 11.2% (3.6-24.2)
Pulmonary artery sling repair (1370) 80 3 1.9 23.8 (4.0-18.2) 17.1 (10.0-24.1) 8.8% (4.3-17.0) 9.8% (5.0-16.5)
DORV, intraventricular tunnel repair (1180) 443 3 2 14.8 (6.0-15.0) 14.9 (12.8-16.9) 13.1% (10.3-16.6) 12.8% (10.0-15.9)
Coarctation repairþVSD repair (1275) 254 3 2 18.2 (7.0-19.0) 17.8 (15.1-20.4) 9.8% (6.8-14.1) 10.2% (7.0-14.0)
Valve replacement, mitral (850) 526 3 2.1 13.9 (6.0-15.0) 14.1 (12.6-15.6) 16.0% (13.1-19.3) 15.5% (12.6-18.7)
Valve replacement, tricuspid (470) 134 3 2.1 12.3 (4.0-11.0) 13.3 (10.0-16.7) 18.7% (13.0-26.1) 16.4% (11.0-22.6)
Valve replacement, truncal valve (250) 11 3 2.1 17.5 (4.0-20.5) 16.2 (8.6-23.9) 18.2% (5.1-47.7) 13.2% (4.5-27.5)
Pulmonary venous stenosis repair (300) 286 3 2.1 18.0 (6.0-21.0) 17.7 (15.1-20.2) 11.5% (8.3-15.8) 11.7% (8.3-15.4)
VSD creation/enlargement (140) 84 3 2.1 12.8 (5.0-13.0) 13.6 (10.4-16.8) 20.2% (13.0-30.0) 16.7% (10.4-24.3)
Fontan revision or conversion (re-do Fontan)
(1025)
107 3 2.2 14.0 (7.0-16.5) 14.4 (12.0-16.7) 18.7% (12.4-27.1) 16.4% (10.8-23.3)
Aortic arch repair (1280) 785 3 2.2 18.4 (6.0-20.0) 18.2 (16.5-20.1) 12.1% (10.0-14.6) 12.2% (10.0-14.6)
Pulmonary atresia VSD (including TOF, PA)
repair (420)
218 3 2.2 17.6 (7.0-15.0) 17.4 (14.3-20.5) 13.8% (9.8-19.0) 13.5% (9.6-17.9)
Valvuloplasty, truncal valve (240) 14 3 2.3 16.6 (4.2-18.8) 16.6 (9.4-23.9) 21.4% (7.6-47.6) 14.8% (5.4-29.0)
TOF - AVC (AVSD) repair (390) 121 3 2.3 17.7 (7.0-19.0) 17.4 (13.8-20.7) 14.9% (9.6-22.3) 14.3% (9.2-20.2)
Ross–Konno procedure (760) 166 3 2.3 16.3 (6.0-14.8) 16.5 (13.5-19.6) 16.9% (11.9-23.3) 15.9% (11.1-21.4)
PA banding (1640) 973 4 2.5 25.1 (6.0-29.0) 24.2 (22.1-26.4) 8.2% (6.7-10.1) 8.6% (7.0-10.4)
Congenitally corrected TGA repair, atrial
switch, and ASO (double switch) (1050)
27 4 2.5 17.0 (8.0-23.0) 17.2 (12.3-22.1) 22.2% (10.6-40.8) 16.8% (8.1-28.7)
Shunt, systemic to pulmonary, modified
Blalock–Taussig shunt (1590)
1966 4 2.5 21.6 (7.0-23.0) 21.5 (20.1-22.8) 12.4% (11.0-13.9) 12.4% (11.0-13.9)
Shunt, systemic to pulmonary, central (from
aorta or to main pulmonary artery) (1600)
482 4 2.5 24.0 (7.0-27.0) 22.8 (19.9-25.6) 10.8% (8.3-13.9) 11.3% (8.6-14.2)
(Continued)
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Procedure name (STS code) No.
Morbidity PLOS (d) Any major complications
Category Score Average (IQR)
Model-based
estimate
(95% CrI) Raw (95% CI)
Model
(95% CrI)
ASO and VSD repair (1120) 670 4 2.6 17.9 (8.0-19.8) 18.0 (16.4-19.6) 17.8% (15.1-20.8) 17.5% (14.8-20.5)
Rastelli (1150) 308 4 2.6 16.4 (6.0-18.0) 16.7 (14.2-19.1) 19.8% (15.7-24.6) 19.0% (14.9-23.4)
TAPVC repair (280) 1327 4 2.6 19.2 (6.0-20.0) 19.1 (17.7-20.6) 16.4% (14.5-18.5) 16.4% (14.4-18.4)
Unifocalization MAPCA(s) (440) 337 4 2.6 19.4 (6.0-21.0) 19.2 (16.4-22.0) 16.6% (13.0-21.0) 16.4% (12.8-20.4)
Transplant, lung(s) (1410) 138 4 2.6 26.8 (13.0-28.0) 23.3 (18.8-27.7) 10.1% (6.1-16.3) 11.9% (7.5-17.1)
Hypoplastic left heart syndrome biventricular
repair (880)
38 4 2.7 33.1 (9.0-31.0) 20.7 (12.8-28.5) 15.8% (7.4-30.4) 16.2% (7.8-27.5)
Aortic arch repairþVSD repair (1285) 353 4 2.8 21.7 (8.0-25.0) 21.4 (19.0-23.7) 15.9% (12.4-20.0) 15.9% (12.3-19.9)
Aortic dissection repair (1390) 35 4 2.9 20.9 (5.0-28.5) 19.9 (14.1-25.5) 22.9% (12.1-39.0) 19.5% (10.5-31.2)
ASD creation/enlargement (60) 100 4 2.9 24.0 (5.0-26.2) 21.5 (16.3-26.6) 18.0% (11.7-26.7) 18.0% (11.6-25.3)
Transplant, heart (890) 821 4 3 23.7 (10.0-27.0) 23.4 (21.8-25.1) 16.6% (14.2-19.3) 16.6% (14.2-19.2)
Mustard (1140) 11 4 3 19.6 (6.0-13.5) 19.5 (11.1-27.7) 36.4% (15.2-64.6) 21.5% (8.1-40.7)
Pulmonary atresia - VSD - MAPCA
(pseudotruncus) repair (430)
98 4 3.1 21.6 (8.0-22.0) 20.8 (16.2-25.3) 22.4% (15.3-31.7) 21.1% (14.1-29.1)
TOF - absent pulmonary valve repair (400) 148 4 3.1 29.7 (6.0-27.8) 24.1 (18.5-29.7) 16.9% (11.7-23.7) 17.6% (12.2-23.6)
Damus–Kaye–Stansel procedure (creation of
aortopulmonary anastomosis without arch
reconstruction) (1660)
313 4 3.3 21.3 (7.0-24.0) 21.2 (18.1-24.3) 23.3% (19.0-28.3) 22.9% (18.6-27.6)
Truncus arteriosus repair (230) 439 4 3.4 26.1 (9.0-27.0) 25.1 (22.1-27.9) 20.0% (16.6-24.0) 20.2% (16.6-23.9)
Interrupted aortic arch repair (1320) 476 4 3.5 28.8 (10.0-35.2) 27.4 (24.6-30.4) 18.7% (15.5-22.4) 19.0% (15.7-22.7)
Transplant, heart and lung (900) 10 4 3.8 40.9 (17.0-53.8) 23.3 (13.7-33.0) 40.0% (16.8-68.7) 26.8% (10.0-48.2)
Arterial switch procedure and VSD
repairþaortic arch repair (1125)
119 5 4.1 23.6 (11.5-29.5) 23.5 (20.3-26.6) 32.8% (25.0-41.6) 31.0% (23.3-39.2)
Arterial switch procedureþaortic arch repair
(1123)
21 5 4.3 26.0 (10.0-31.0) 24.4 (17.9-30.7) 42.9% (24.5-63.5) 32.7% (18.0-50.3)
Norwood procedure (870) 2273 5 4.9 34.6 (14.0-42.0) 34.1 (32.6-35.7) 29.6% (27.7-31.5) 29.7% (27.9-31.6)
Truncusþ IAA repair (3200) 34 5 5 32.6 (13.0-36.0) 27.3 (20.3-34.2) 44.1% (28.9-60.5) 38.2% (24.8-52.9)
PLOS, Postoperative length of stay; STS, Society of Thoracic Surgeons; IQR, interquartile range; CrI, credible interval; CI, confidence interval; ASD, atrial septal defect; ICD,
implantable cardioverter defibrillator; AICD, automatic implantable cardioverter defibrillator; PAPVC, partial anomalous pulmonary venous connection; AVSD, atrioventricular
septal defect; PAVSD, partial atrioventricular septal defect;DCRV, double-chambered right ventricle; VSD, ventricular septal defect; LV, left ventricle; PA, pulmonary artery; AVC,
atrioventricular canal; TOF, tetralogy of Fallot; PFO, patent foramen ovale; AVR, aortic valve replacement; RVOT, right ventricular outflow tract; TCPC, total cavopulmonary
connection; PDA, patent ductus arteriosus; RV, right ventricle; AVC, atrioventricular canal; MAPCA, major aortopulmonary collateral artery; TGA, transposition of the great
arteries; REV, reparation a l’etage ventriculaire; DORV, double-outlet right ventricle; ASO, arterial switch operation; TAPVC, total anomalous pulmonary venous connection;
IAA, interrupted aortic arch.
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weighted combination of complication rate þ average
PLOS, strong consideration was given to an alternative
composite consisting of the rate of major complications
and the average time on ventilator. Rank correlation be-
tween these 2 composite morbidity measures was 0.93, sug-
gesting that the 2 methods tend to give similar, but not
completely identical, results. The version using PLOS was
preferred in part because PLOS was collected with high
(>99.9%) completeness, whereas ventilation time was
more than 15% missing. Moreover, during the time period
of this study, the STS definition of time on ventilator only
included the time until the first extubation and did not in-
clude the additional time on ventilator for patients who
were subsequently reintubated.
Fourth, we assessed the reliability (ie, statistical preci-
sion; see ‘‘Materials andMethods’’) of the various measures
that were used for ranking procedures in this study. For1052 The Journal of Thoracic and Cardiovascular Surmajor complications, average PLOS, and the composite
morbidity measure, the estimated reliability values were
0.80 (95% CrI, 0.71-0.87), 0.88 (95% CrI, 0.82-0.92),
and 0.90 (95% CrI, 0.85-0.94), respectively. Thus, reliabil-
ity was greatest for composite morbidity, which was the ba-
sis of the proposed Morbidity Score and Categories. The
estimated reliability of composite morbidity increased to
0.95 (95% CrI, 0.92-0.97) when considering only proce-
dures with at least 30 cases (N ¼ 115 procedures) and to
0.99 (95% CrI, 0.98-0.99) when considering only proce-
dures with at least 200 cases (N ¼ 67 procedures).
Finally, we assessed the degree of association between
the proposed Morbidity Score and the existing STS-
EACTSMortality Score. Aweak association would suggest
poor content validity because, conceptually, we know that
morbidity and mortality are closely related. On the other
hand, a perfect association would suggest that the morbidity
score is redundant with mortality and thus is unneeded.gery c April 2013
TABLE 2. Major complications
Complication description (STS code*)
No. (%) of
eventsy
Mortality
N (%)
Rank correlation with
‘‘major complication’’
Postoperative acute renal failure requiring temporary or permanent dialysis (220 or 230) 705 (1.1%) 396 (56.2%) 0.59
Postoperative neurologic deficit persisting at discharge (320) 500 (0.8%) 152 (30.4%) 0.45
Postoperative AV block requiring permanent pacemaker (60) 593 (0.9%) 28 (4.7%) 0.37
Postoperative mechanical circulatory support (IABP, VAD, ECMO, or CPS) (40) 1110 (1.8%) 617 (55.6%) 0.54
Phrenic nerve injury/paralyzed diaphragm (300) 578 (0.9%) 35 (6.1%) 0.40
Unplanned reoperation (20 or 240) 2942 (4.7%) 636 (21.6%) 0.79
Major complication (defined as any 1 or more of the above) 5059 (8.0%) 1187 (23.5%) N/A
STS, Society of Thoracic Surgeons; AV, atrioventricular; IABP, intra-aortic balloon pump; VAD, ventricular assist device; ECMO, extracorporeal membrane oxygenation; CPS,
cardiopulmonary support. *Complication codes in the STSCHSD Data Collection Form, Version 2.50.18 yDenominator is 62,851 operations.
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the STS-EACTS Mortality Score were plotted and com-
pared. As shown in Figure 3, they are closely related
(rank correlation ¼ 0.79), but far from being redundant.
Descriptive characteristics of the 5 Morbidity categories
are shown in Table 3. The association between Morbidity
Categories and Mortality Categories is summarized in
Table 4. TheMorbidity andMortality Categories were iden-
tical for 74 procedures, differed by 1 or fewer positions for
135 procedures, and differed by 2 or fewer positions for 139
procedures. One procedure (pulmonary artery debanding)
was in category 4 for mortality but category 1 for morbidity.
DISCUSSION
Measuring morbidity is a challenging but important ele-
ment of outcomes reporting and quality assessment.7,8
Morbidity is a major determinant of health status afterFIGURE 1. Unadjusted average PLOS (days) and unadjusted rate of ma-
jor complications (percentage) are measured on the horizontal and vertical
axes, respectively. Squares represent the 140 procedure types with n greater
than 10. PLOS, Postoperative length of stay.
The Journal of Thoracic and Carsurgery and of hospital cost.3,4,8 The importance of
developing a morbidity metric was articulated in 2004 by
Phillipe Kolh,9 who described quantitation of morbidity in
cardiac surgery as follows: ‘‘Being more frequent than mor-
tality, it could carry more information and be measured in
terms of postoperative complications and length of hospital
stay.. Furthermore, because of the heterogeneity of mor-
bidity events, future scoring systems should probably gen-
erate separate predictions for mortality and major
morbidity events.’’ In this report, we introduce an empiri-
cally derived tool that estimates the relative risk of morbid-
ity associated with congenital heart surgery procedures on
the basis of elements of both complications and PLOS.
Formal risk modeling using logistic regression is practi-
cal for common ‘‘adult cardiac procedures,’’ such as coro-
nary artery bypass grafting and valve replacement. No
operation for congenital heart disease is performed inFIGURE 2. The proportions (%) of Any Major Complication and of Any
Major Complication or Mortality are measured on the horizontal and ver-
tical axes, respectively. The squares represent the 140 procedure types with
n greater than 10.
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FIGURE 3. The relationship between the STS-EACTS Mortality score2
and the STS Morbidity Score. Squares represent the 140 procedure types
with n greater than 10.
TABLE 4. Association between morbidity categories and mortality
categories
Mortality categories
1 2 3 4 5
Morbidity categories 1 21 13 1 1 0
2 5 26 10 2 0
3 0 12 10 13 1
4 0 0 3 15 3
5 0 0 0 2 2
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The diverse spectrum of distinct procedures is reflected by
140 procedure types in this study. Bayesian modeling is
a particularly appropriate tool in this setting where denom-
inators may be small. Thus, the product of this analysis is
not a series of procedure-specific risk models, but rather
a metric of procedure-based estimates of morbidity that
can be used to describe case mix.
Composite Development
At the outset, we appreciated the importance of including
both a complications element and a resource utilization
element in a morbidity metric. We felt obligated, however,
to demonstrate that use of either alone would be inadequate,
that is, a model that assumed a direct 1-to-1 relationship be-
tween major complications and PLOS would not fit the data
as well, and therefore be an incomplete and less informative
morbidity metric.
Resource utilization variables used in previous analyses
were considered. Analysis based on inclusion of ventilation
time is described earlier in this article. Previous analyses
from individual institutions have included length of
intensive care unit (ICU) stay.10,11 It is less useful atTABLE 3. Summary of morbidity categories
1 2 3 4 5
No. of procedures 36 43 36 21 4
Aggregate average PLOS (d) 6.3 11.3 15.2 22.3 34.0
Rate of major complications 3.2% 6.5% 11.9% 15.2% 30.0%
PLOS, Postoperative length of stay.
1054 The Journal of Thoracic and Cardiovascular Sura multi-institutional level because of lack of a uniform defi-
nition of ICU, and because some institutions keep postoper-
ative patients in an ICU environment until discharge. Cost is
another measure of resource utilization that may be associ-
ated with morbidity. Cost data are not included in STS regis-
tries; furthermore, true cost data can be difficult to estimate.
Individual elements of the complication end point were
considered on the basis of their potential impact on pa-
tients’ health status, including durable, long-lasting ef-
fects. We acknowledge that validated data describing
relationships between some individual complications and
late health status are not readily available. Some compli-
cations that are not included, such as Postoperative Car-
diac Arrest, have been evaluated in other studies and
shown to potentially be associated with mortality.12 De-
spite the fact that all complication codes in the STSCHSD
have corresponding definitions since 2006, the coding of
complications such as Postoperative Cardiac Arrest may
still be subject to a degree of interpretation, and thus
potentially variable ascertainment, in contrast to compli-
cations included in our list, such as postoperative mechan-
ical circulatory support. Still other complications, such as
sternal dehiscence and mediastinitis, are not included in
this metric because they result in unplanned reoperations,
and thus are accounted for in the composite. A variety of
other complications that are not counted in the major
complications end point are likely to be reflected in in-
creased PLOS. Although some have argued that mortality
is the ‘‘ultimate morbidity,’’ the decision to exclude
in-hospital mortality from the morbidity metric was delib-
erate, based on several principles. First, the Morbidity
Scores and Categories are designed to be used in conjunc-
tion with the STS-EACTS Mortality Scores and Cate-
gories. Second, analyses of potential associations
between morbidity and mortality require the use of sepa-
rate metrics for each.9,13
Our analysis confirms that morbidity and mortality
indices provide related but not redundant information.
Outcomes assessment should include measures of both,
as suggested by Kohl.9 The decision to include patients
who died before discharge may seem obvious, but it
was debated. An alternative strategy that eliminates
from analysis those who died before discharge would
have resulted in an incomplete and potentially misleadinggery c April 2013
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possible efforts to explore relationships between morbid-
ity and mortality. The concept of ‘‘Failure to Rescue,’’ that
is, probability of death following the occurrence of a compli-
cation or adverse event, is emerging as a potentially impor-
tant tool for measuring performance and directing quality
improvement initiatives.14,15 Quantitative estimation of
morbidity only among hospital survivors would overlook
the importance of this concept.
Widely used systems for stratifying risk or complexity of
congenital heart surgery procedures have focused entirely
on in-hospital mortality16 or included a morbidity element
that was based on expert opinion rather than objective
data.17 The Morbidity Score and Categories presented in
the current study are complementary to the empirically
based STS-EACTS Mortality Score and Categories2 and
were derived using data in the largest congenital heart sur-
gery registry.
Study Limitations
Despite the advantages of an empirically based tool for
analyzing morbidity, this study has important limitations.
The analysis focuses on estimation of morbidity at the pro-
cedure level. We did not address methods of incorporating
these procedural variables into statistical models for per-
forming inter-institutional outcomes comparisons. Nor
does our methodology address the appropriateness and tim-
ing of individual procedures in relation to overall disease
management or include consideration of patient-specific
risk factors. Second, despite a large database size, it is pos-
sible that patients and data in the STSCHSD are not entirely
representative of other populations. Third, several individ-
ual procedures had small sample sizes, and the true morbid-
ity associated with these procedures may have been
estimated with error. We attempted to minimize this error
by using a composite measure that combines statistical in-
formation from several related end points into a single
end point. Fourth, both the occurrence and the impact
of morbidity extend beyond the duration of the surgical
hospital admission. The nature of the STSCHSD precludes
inclusion of complications recognized or therapeutic inter-
ventions occurring after discharge from the ‘‘surgical ad-
mission.’’18 A ‘‘long-term database’’ will ultimately be
needed to achieve a more comprehensive estimation of mor-
bidity associated with surgery for congenital heart disease.
This study represents an important first step and acknowl-
edges the need for a quantitative morbidity metric and the
mandate that it be empirically derived.
CONCLUSIONS
The STS Morbidity Score and Categories is a tool for an-
alyzing morbidity associated with operations for congenital
heart disease and for grouping procedures with similarThe Journal of Thoracic and Carempirically estimated risk of morbidity. Together with the
STS-EACTS Mortality Score and Categories, this tool en-
hances our ability to accurately characterize case mix. It
should add a new dimension and precision to outcome as-
sessments and may provide important information to guide
quality-improvement initiatives.References
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APPENDIX 1. STATISTICAL APPENDIX
Statistical Model
A bivariate hierarchical model with normally distributed
random effects was used to estimate the distribution of
procedure-specific probabilities of major complication
and average PLOS. For the i-th patient undergoing the
j-th procedure, let yji denote the occurrence of major com-
plication (0 ¼ no, 1 ¼ yes) and xji denote the patient’s
PLOS. The model was as follows:
yjiiid BernoulliðpjÞ; xjiiid Normalðmj; s2j Þ;
pj ¼ 1=

1þexphj
ðhj;mjÞ  BivariateNormalðm;PÞ
where pj denotes the unknown theoretic probability of ma-
jor complication for the j-th procedure; mj and s
2
j denote the
unknown mean and variance of PLOS for the j-th proce-
dure; and m,
P
denote unknown parameters of the assumed
bivariate normal random effects distribution.
Estimation
Model parameters were estimated in a Bayesian statisti-
cal framework by specifying a prior probability distribution
for unknown parameters m,
P
, and s21;.; s
2
148. Because our
prior knowledge was limited, we specified a vague proper
prior distribution that consisted of independent normal dis-
tributions for the elements of m, independent inverse
Gamma distributions for the s2j s, and an inverse Wishart
distribution for
P
. Posterior means and CrIs were
calculated using Markov Chain Monte Carlo (MCMC)
simulations as implemented in WinBUGS version 1.4
software (Medical Research Council Biostatistics Unit,
Cambridge, UK, and the Imperial College School of Medi-
cine at St Mary’s, London, UK).19 Posterior summaries
were based on 4000 sets of simulated parameter values gen-
erated after a long burn-in period to ensure convergence.
Composite Morbidity
The overall composite morbidity of the j-th procedure
was defined as follows:
qj ¼ pj
sp
þmj
sm
where
sp ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
148
X148
j¼1
 
pj 1
148
X148
h¼1
ph
!2vuut and
sm ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
148
X148
j¼1
 
mj
1
148
X148
h¼1
mh
!2vuut :
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l¼1
where q
ðlÞ
j denotes the simulated value of qj at the l-th
iteration of the MCMC procedure. A 95% Bayesian CrI
for qj was obtained by calculating the 100th lowest and
100th highest values of qðlÞ across the 4000 simulated
values.
Creation of Categories
To create internally homogeneous categories, procedures
were first sorted in order of increasing estimated morbidity
and then grouped by choosing cutpoints that were optimal
according to a least squares variance criterion, as described
later. We first sorted procedures so that bq1<bq2</<bq148.
Let K denote the number of categories and let
cK ¼ c1<c2</<cK1 denote a set of category cutpoints
that partition the categories into K groups. The symbol cK
denotes a number between 1 and 148 and represents the in-
dex of the highest-morbidity procedure in the k-th category.
Also, define c0¼ 0 and cK¼ 149. For any particular choice
ofK and cK, within-category homogeneity was measured by
the weighted sum-of-squares criterion:
WSSðcK ; qÞ ¼
XK
k¼1
Xck
j¼ck1þ1
nj

qjqk
2
where nj is the number of patients in the denominator for the
j-th procedure and qk ¼
Xck
j¼ck1þ1
njqj
. Xck
j¼ck1þ1
nj is the average
morbidity of all procedures in the k-th category weighted by
their respective sample sizes. If the qj were known instead of
unknown, then the ‘‘optimal’’ cutpoints could (in theory) be
determined by enumerating all possible choices for the ck
and choosing the one that minimizes the WSS. Because the
qj are unknown, we instead chose cutpoints that minimize
the estimated value of WSS (cK). Specifically, we chose cut-
points that minimize the posterior mean
dWSSðcKÞ ¼ 1
4000
X4000
l¼1
WSS

cK ; q
ðlÞ
where qðlÞ is the value of q ¼ ðq1;.; q148Þ on the l-th iter-
ation of the MCMC procedure. An unpublished dynamic
programming algorithm was used to determine the set of
cutpoints that made this quantity a minimum. TheWSS cri-
terion gets smaller asK, the number of categories, increases.
The value K ¼ 5 was selected for consistency with the pub-
lished STS-EACTS mortality categories.
Estimation of Reliability
Reliability is conventionally defined as the proportion of
variation in a measure that is due to true between-unit
gery c April 2013
differences (ie, signal) as opposed to random statistical fluc-
tuations (ie, noise). Equivalently, it is the squared correla-
tion between a measurement and the true value.
Accordingly, reliability was defined as the square of the
Pearson correlation coefficient between the set of
procedure-specific estimates bq1;.; bq148 and the corre-
sponding unknown true values q1;.; q148, that is:
r2 ¼
"X148
j¼1
 bqj 1
148
X148
h¼1
bqh! qj 1
148
X148
h¼1
qh
!#2
"X148
j¼1
 bqj 1
148
X148
h¼1
bqh!2#"X148
j¼1
 
qj 1
148
X148
h¼1
qh
!2#
The quantity r2 was estimated by its posterior mean,
namely
br2 ¼ 1
4000
X4000
l¼1
r2ðlÞ
where
r2ðlÞ ¼
"X148
j¼1
 bqj 1
148
X148
h¼1
bqh
! 
q
ðlÞ
j 
1
148
X148
h¼1
q
ðlÞ
h
!#2
"X148
j¼1
 bq j 1
148
X148
h¼1
bqh
!2#"X148
j¼1
 
q
ðlÞ
j 
1
148
X148
h¼1
q
ðlÞ
h
!2#
with q
ðlÞ
j denoting the value of qj at the l-th MCMC iteration
and bqj ¼X4000
l¼1
q
ðlÞ
j
.
4000 denoting the posterior mean of qj. A
95%CrI for r2 was obtained by calculating the 100th small-
est and 100th largest values of r2ðlÞ across the 4000 MCMC
iterations. Analogous calculations were used to estimate re-
liability for subsets of procedures with at least 10, 30, or 200
cases. An identical approach was also used for estimating
the reliability of procedure-specific probability parameters
p1;.;p148 and mean parameters m1;.;m148.
APPENDIX 2. CLASSIFICATION OF MULTIPLE-
PROCEDURE OPERATIONS
Several procedures listed in Table 1 are actually combi-
nations of 2 or more procedures. These combinations
were previously identified during development of the
STS-EACTS Mortality Score and Categories.2 They occur
frequently in the STS and EACTS databases, and the com-
plexity of the combination is regarded as being different
from the complexity of the component procedures when
performed in isolation. For all other operations involving
combinations of procedures, the operation was classified
according to the most technically complex procedure, as de-
termined by the difficulty component of the 2007 update of
the Aristotle Basic Complexity score. The Aristotle Basic
Complexity score contains some ties and is not defined
for 3 of the procedures listed in Table 1. To deal with unde-
fined or tied Aristotle scores, 6 of the study authors indepen-
dently ranked the difficulty of each procedure. Undefined or
tied Aristotle scores were adjudicated by assigning the op-
eration to the procedure with the highest average ranking
determined by the 6 graders. The difficulty rankings were
published together with the STS-EACTS Mortality Score
and Categories.2 The identical methodology and rankings
were used to classify multiple-procedure operations during
development of the STS Morbidity Score and categories.
APPENDIX 3. RESCALING OF INDIVIDUAL
OUTCOME MEASURES (AVERAGE RISK OF
MAJOR COMPLICATIONS AND AVERAGE
POSTOPERATIVE LENGTH OF STAY)
Procedure-specific complication rates are percentages
measured on a scale from 0 to 100. Procedure-specific aver-
age PLOS is measured in days ranging from 0 to infinity.
These are different measurement scales. We rescaled these
so that the new scales would have approximately the same
standard deviation. This guarantees that approximately half
of the variation of the composite measure will be attributable
to complications and half to PLOS. If we did not rescale
them, then the amount of variation contributed by each
itemwould be dependent on the scale we used for measuring
it. For example, we would get different results depending on
whether complication rates were expressed as percentages or
proportions, or whether PLOSwasmeasured in days, weeks,
or months. Rescaling makes it possible to have a composite
measure in which dominance of a single element is avoided.
For complications, first, we calculated each procedure’s
complication rate. Next, we calculated the standard devia-
tion of the set of procedure-specific complication rates.
Finally, to obtain a rescaled complication rate, we divided
each of the original 140 complication rates by their common
standard deviation. The same process was used for stan-
dardizing average PLOS.
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FIGURE E1. The relationship between the number of categories and the
degree of within-category homogeneity. Within-category homogeneity is
defined as 1 minus the ratio of within-category variance to total variance
of procedure-specific morbidity estimates.
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